Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report (2006)

Chapter: Appendix A Participants and Invited Experts - Between December 1, 2004 and June 27, 2005

Previous Chapter: References
Suggested Citation: "Appendix A Participants and Invited Experts - Between December 1, 2004 and June 27, 2005." Institute of Medicine. 2006. Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11561.

A
Participants and Invited Experts Between December 1, 2004, and June 27, 2005

Participants

December 1, 2004


Alan Breier

Vice President, Medical, and Chief Medical Officer

Eli Lilly and Company


Catherine D.DeAngelis

Editor-in-Chief

Journal of the American Medical Association


Jeffrey M.Drazen

Editor-in-Chief

New England Journal of Medicine


Lawrence Hirsch

Executive Director, Medical Communications

Merck Research Laboratories


Richard Kingham

Partner

Covington & Burling


Ronald Krall

Senior Vice President, World Wide Development, GlaxoSmithKline Pharmaceuticals


Alexa McCray

Director, Lister Hill National Center for Biomedical Communications

National Library of Medicine


Lana Skirboll (via phone)

Associate Director of Science Policy

Office of the Director

National Institutes of Health


Harold C.Sox

Editor

Annals of Internal Medicine


Melvyn L.Sterling

Chair, Council on Scientific Affairs

American Medical Association


Robert Temple (via phone)

Director, Office of Medical Policy

Center for Drug Evaluation and Research

U.S. Food and Drug Administration


Elias Zerhouni (via phone)

Director

National Institutes of Health

Suggested Citation: "Appendix A Participants and Invited Experts - Between December 1, 2004 and June 27, 2005." Institute of Medicine. 2006. Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11561.

Invited Experts

Between December 1, 2004, and June 27, 2005


Alan Breier

Vice President, Medical and Chief Medical Officer

Eli Lilly and Company


Catherine D.DeAngelis

Editor-in-Chief

Journal of the American Medical Association


Jeffrey M.Drazen

Editor-in-Chief

New England Journal of Medicine


Lawrence Hirsch

Executive Director, Medical Communications

Merck Research Laboratories


John Hoey

Editor

Canadian Medical Association Journal


Christine Laine

Executive Secretary

Annals of Internal Medicine


Justin McCarthy

General Counsel, Pfizer Global Research and Development

Pfizer, Inc.


Frank Rockhold

Senior Vice President and Director, Biomedical Data Sciences

GlaxoSmithKline Pharmaceuticals Research and Development


Alfred Sandrock

Vice President, Medical Research-Neurology

Biogen Idec


Ralph Smalling

Vice President, Global Research and Development Policy Analysis

Amgen


Harold Sox

Editor

Annals of Internal Medicine

Suggested Citation: "Appendix A Participants and Invited Experts - Between December 1, 2004 and June 27, 2005." Institute of Medicine. 2006. Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11561.
Page 49
Suggested Citation: "Appendix A Participants and Invited Experts - Between December 1, 2004 and June 27, 2005." Institute of Medicine. 2006. Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report. Washington, DC: The National Academies Press. doi: 10.17226/11561.
Page 50
Next Chapter: Appendix B Workshop Agenda, Speakers, Panelists, and Participants - June 27, 2005
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.